Advert

Stem cell go-ahead puts Obama at odds with Pope

US President Barack Obama's lifting of restrictions on federal funding for human embryonic stem cell research puts him at odds with Pope Benedict and the American Roman Catholic Church.

After Mr Obama signed the order on Monday, the Vatican and US Church leaders condemned the move. One commentator said the test of "a real democracy" was its defence of the most defenceless.

Mr Obama's executive order reversed and repudiated restrictions placed on the research by his predecessor, George W. Bush, freeing labs across the country to start working with the cells, which can give rise to any kind of cell in the body.

Cardinal Justin Rigali of Philadelphia, chairman of the US Conference of Catholic Bishops' committee on pro-life activities, called Mr Obama's decision "a sad victory of politics over science and ethics".

"This action is morally wrong because it encourages the destruction of innocent human life, treating vulnerable human beings as mere products to be harvested," he added.

The Catholic Church, other religious groups and pro-life advocates oppose such research - which scientists hope can lead to cures for diseases such as Alzheimer's and Parkinson's - because it involves the destruction of embryos.

The Catholic Church supports adult stem cell research, which has made advances in recent years, because it does not involve the destruction of embryos.

An article in the Vatican newspaper L'Osservatore Romano yesterday said "a real democracy" should be founded on protection of human dignity in every phase of its existence.

Separately, Osservatore's editor-in-chief Gian Maria Vian told an Italian newspaper that Mr Obama "cannot claim a monopoly on being the Good Samaritan" by saying he supports embryonic stem cell research in order to help alleviate human suffering.

"Does that mean those who oppose embryonic stem cell research want to prolong human suffering?" Mr Vian said.

Mgr Elio Sgreccia, a leading Vatican bioethics specialist, told Italian media: "The motive for this decision should be seen in the pressure for profits."

After the ban was lifted on Monday, US shares in stem cell research companies soared. Researchers said companies that had been afraid to test the waters would probably leap in now that federal dollars can be used.

Advert

6 Comments

Post comment

Comments are submitted under the express understanding and condition that the editor may, and is authorised to, disclose any/all of the above personal information to any person or entity requesting the information for the purposes of legal action on grounds that such person or entity is aggrieved by any comment so submitted.

At this time your comment will not be displayed immediately upon posting. Please allow some time for your comment to be moderated before it is displayed.

Your User Profile is incomplete.
Please click here to complete your profile before posting comments.

Advert
Advert